RUSSO, ALESSANDRO

RUSSO, ALESSANDRO  

Mostra records
Risultati 1 - 20 di 28 (tempo di esecuzione: 0.041 secondi).
Titolo Data di pubblicazione Autore(i) File
1995PApplication of ESCAT and OncoKB scales in liquid biopsy (LB) in advanced NSCLC patients (pts): Is it feasible and reliable? 1-gen-2019 Mccusker, M G; Russo, A; Chen, J; Scilla, K A; Mehra, R; Rolfo, C D
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives 1-gen-2015 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria; Picone, Antonio; Ferraro, Giuseppa; Zanghì, Mariangela; Toscano, Giuseppe; Giordano, Antonio; Adamo, Vincenzo
Acquired resistance in oncogene-addicted non-small-cell lung cancer 1-gen-2018 Sini, C.; Tuzi, A.; Rossi, G.; Russo, A.; Pezzuto, A.
Baseline neutrophilia, derived neutrophil-to-lymphocyte ratio (dNLR), platelet-to-lymphocyte ratio (PLR), and outcome in non small cell lung cancer (NSCLC) treated with Nivolumab or Docetaxel 1-gen-2018 Russo, A.; Franchina, T.; Ricciardi, G. R. R.; Battaglia, A.; Scimone, A.; Berenato, R.; Giordano, A.; Adamo, V.
Can we better manage advanced NSCLC in the elderly with the new therapeutic agents? Preliminary analysis of a real life multicenter study. 1-gen-2017 Franchina, T; Novello, S; Russo, A; Gianetta, M; Capelletto, E; Galetta, D; Catino, A; Migliorino, Mr; Ricciardi, S; Morgillo, F; Della Corte, Cm; Rocco, D; Soto Parra, Hj; Russo, A; Ambrosio, F; Franchina, V; Adamo, V
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance 1-gen-2016 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria Rita; Ferraro, Giuseppa; Scimone, Antonino; Bronte, Giuseppe; Russo, Antonio; Rolfo, Christian; Adamo, Vincenzo
Concomitant medications during immune checkpoint blockage in cancer patients: Novel insights in this emerging clinical scenario 1-gen-2019 Rossi, Giovanni; Pezzuto, Aldo; Sini, Claudio; Tuzi, Alessandro; Citarella, Fabrizio; Mccusker, Michael G.; Nigro, Olga; Tanda, Enrica; Russo, Alessandro
Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases 1-gen-2015 Ricciardi, Giuseppina Rosaria Rita; Russo, Alessandro; Franchina, Tindara; Ferraro, Giuseppa; Adamo, Vincenzo
Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: New directions for systemic therapy - a case report and literature review 1-gen-2018 Ricciardi, Giuseppina Rosaria Rita; Russo, Alessandro; Franchina, Tindara; Schifano, Silvia; Mastroeni, Giampiero; Santacaterina, Anna; Adamo, Vincenzo
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer 1-gen-2017 Picciotto, Maria; Franchina, Tindara; Russo, Alessandro; Ricciardi, Giuseppina Rosaria Rita; Provazza, Giusy; Sava, Serena; Baldari, Sergio; Caffo, Orazio; Adamo, Vincenzo
Exosomal PD-L1 expression and dynamic changes of immune response associated cytokines as predictive biomarkers for immune checkpoint blockage with PD-1/PD-L1 inhibitors in advanced/metastatic non-small cell lung cancer 30-ott-2019 Russo, Alessandro
Heterogeneous responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with uncommon EGFR mutations: New insights and future perspectives in this complex clinical scenario 1-gen-2019 Russo, A.; Franchina, T.; Ricciardi, G.; Battaglia, A.; Picciotto, M.; Adamo, V.
How I treat ALK-positive non-small cell lung cancer 1-gen-2019 Mccusker, Michael G; Russo, Alessandro; Scilla, Katherine A; Mehra, Ranee; Rolfo, Christian
Immunotherapy use in patients with HIV and non-small-cell lung cancer: Current data 1-gen-2019 Rolfo, Christian; Scilla, Katherinea; Russo, Alessandro
Impact of circulating microRNAs mir-22, mir-24 and mir-34a on response to pemetrexed in patients with non small cell lung cancer 1-gen-2012 Franchina, Tindara; Amodeo, V; Proto, Claudia; Bronte, G; Savio, G; Russo, Alessandro; Toscano, G; Russo, A; Adamo, Vincenzo
Impact of erlotinib on overall survival in non small cell lung cancer patients: is the post progression survival a new paradigm? 1-gen-2013 Franchina, Tindara; Russo, Alessandro; Proto, C; Chiofalo, G; Picciotto, Maria; Scimone, A; Toscano, G; Berenato, R; Noto, L; Adamo, Vincenzo
Influence of EGFR mutational status on metastatic behavior in non squamous non small cell lung cancer 1-gen-2017 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria Rita; Fanizza, Caterina; Scimone, Antonino; Chiofalo, Giuseppe; Giordano, Antonio; Adamo, Vincenzo
Is There Room for Personalized Medicine in Small-Cell Lung Cancer (SCLC)? Remarkable Activity of Pazopanib in Refractory FGFR1-Amplified ED-SCLC 1-gen-2019 Russo, Alessandro; Ron, David Arias; Rasschaert, Marika; Prenen, Hans; Mehra, Ranee; Scilla, Katherine; Pauwels, Patrick; Rolfo, Christian
Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study 1-gen-2019 Singhal, Sandeep; Rolfo, Christian; Maksymiuk, Andrew W; Tappia, Paramjit S; Sitar, Daniel S; Russo, Alessandro; Akhtar, Parveen S; Khatun, Nazrina; Rahnuma, Parveen; Rashiduzzaman, Ahmed; Ahmed Bux, Rashid; Huang, Guoyu; Ramjiawan, Bram
Liquid biopsy tracking of lung tumor evolutions over time 1-gen-2019 Russo, A.; De Miguel Perez, D.; Gunasekaran, M.; Scilla, K.; Lapidus, R.; Cooper, B.; Mehra, R.; Adamo, V.; Malapelle, U.; Rolfo, C.